scholarly journals Pengaruh Zat Besi (Tablet Fe) Terhadap Berat Badan Lahir Pada Ibu Bersalin Normal

2020 ◽  
Vol 10 (1) ◽  
pp. 470-475
Author(s):  
Zulliati Zulliati ◽  
Nita Hestiyana
Keyword(s):  
Systematic Review ◽  
Birth Weight ◽  
Controlled Trial ◽  
Congenital Defects ◽  
Attractive Alternative ◽  
Scientific Article ◽  
Viet Nam ◽  
Anemia In Pregnancy ◽  
Infant Birth ◽  
In Pregnancy

 Latar Belakang: Anemia dalam kehamilan mempengaruhi lebih dari 500 juta wanita dalam masa kehamilan, yang nantinya dapat dikaitkan dengan gangguan pada ibu dan bayi. Suplementasi zat besi selama masa kehamilan diberikan secara terus menerus adalah alternatif yang menarik. Anemia sering terjadi akibat defisiensi zat besi dikarenakan pada ibu hamil terjadi peningkatan kebutuhan zat besi dua kali lipat akibat peningkatan volume darah tanpa ekspansi volume plasma, untuk memenuhi kebutuhan ibu (mencegah kehilangan darah pada saat melahirkan) dan pertumbuhan janin.Tujuan: Artikel ilmiah ini mencoba menelaah berdasarka studi literature hasil penelitian mengenai penggunaan tablet zat besi terhadap peningkatan berat badan lahir bayi.  Metode: Studi ini merupakan tinjauan literatur yang dilakukan dari tiga jurnal penelitian yang dilakukan di Viet Nam dan Spayol dan systematic review dari beberapa Randomized Controlled Trial yang dilakukan di cluster dan communityHasil: Beberapa penelitian menyebutkan terdapat korelasi yang erat antara anemia pada saat kehamilan dengan kematian janin, abortus, cacat bawaan, berat bayi lahir rendah, cadangan zat besi yang berkurang pada anak atau anak lahir dalam keadaan anemia gizi.Kesimpulan: Pemberian zat besi selama kehamilan selama ini diyakini  dapat mengatasi anemia dalam kehamilan untuk menghindari persalinan prematur dan perdarahan pada saat persalinan,Kata kunci :Berat badan lahir, zat besi ABSTRACT Background: Anemia in pregnancy affects more than 500 million women during pregnancy, which can later be associated with disorders of the mother and baby. Iron supplementation during pregnancy is given continuously is an attractive alternative. Anemia often occurs due to iron deficiency because in pregnant women there is a doubling of iron demand due to increased blood volume without plasma volume expansion, to meet the needs of the mother (preventing blood loss during childbirth) and fetal growth.Purpose: This scientific article tries to examine the literature based on the results of research on the use of iron tablets to increase infant birth weight.Methods: This study is a literature review conducted from three research journals conducted in Viet Nam and Spain and a systematic review of several Randomized Control Trials conducted in clusters and communities.Results: Several studies suggest that there is a close correlation between anemia during pregnancy and fetal death. , abortion, congenital defects, low birth weight, reduced iron reserves in children or children born in a state of nutritional anemia.Conclusion: The administration of iron during pregnancy is believed to be able to overcome anemia in pregnancy to avoid premature labor and bleeding during labor, Keywords: Birth weight, iron

scholarly journals A retrospective study of the health profile of neonates of mothers with anemia in pregnancy and pregnancy induced hypertension in Lagos, Nigeria

2014 ◽  
Vol 5 (2) ◽  
Author(s):  
Olusola Funmilayo Sotunde ◽  
Silifat Ajoke Sanni ◽  
Oluseye Olusegun Onabanjo ◽  
Ibiyemi O. Olayiwola ◽  
Mure Agbonlahor
Keyword(s):  
Retrospective Study ◽  
Birth Weight ◽  
Sampling Technique ◽  
Neonatal Health ◽  
Pregnancy Induced Hypertension ◽  
Health Profile ◽  
Maternal Complications ◽  
Induced Hypertension ◽  
Anemia In Pregnancy ◽  
In Pregnancy

Our study assessed the health profile of neonates in relation to anemia in pregnancy and pregnancy induced hypertension (PIH). This was a retrospective study where a systematic random sampling technique was used to select a total of 1046 case records of pregnant women registered for ante-natal care at Lagos Island Maternity Hospital, Lagos, Nigeria, between 2005 and 2009. Socio-demographic characteristics of the mothers, prevalence of anemia and PIH, and neonatal health profile were obtained from the case records and were analyzed using both descriptive and inferential statistics. Pearson product moment correlation was used to show the relationship (P≤0.05) between maternal complications and neonatal health profile. Majority (68.8%) of the mothers had anemia and 6.7 % had PIH. Majority (97.12%) of the neonates were live births and 2.88% of the neonates were still births, 65.4% of the women with still birth pregnancy outcome had anemia, and 34.6% had PIH. Majority (74%) of the neonates had birth weight within normal range (2.5-4.0 kg) and majority (68%) had normal Apgar score at 5 min of birth (7- 10). A positive correlation existed between the packed cell volume of the mother and the birth weight of the neonates (r=0.740, P≤0.05). A negative correlation existed between the incidence of PIH and the birth weight of the neonates (r=

scholarly journals Fish Oil Supplementation in Pregnancy Increases Gestational Age, Size for Gestational Age, and Birth Weight in Infants: A Randomized Controlled Trial

2018 ◽  
Vol 149 (4) ◽  
pp. 628-634 ◽  
Author(s):  
Rebecca Kofod Vinding ◽  
Jakob Stokholm ◽  
Astrid Sevelsted ◽  
Bo L Chawes ◽  
Klaus Bønnelykke ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Birth Weight ◽  
Pregnant Women ◽  
Gestational Age ◽  
Controlled Trial ◽  
Growth Curves ◽  
Vitamin D Supplementation ◽  
Double Blind ◽  
Randomized Controlled ◽  
In Pregnancy

ABSTRACT Background Randomized trials have reported that supplementation with n–3 long-chain polyunsaturated fatty acids (LCPUFAs) in pregnancy can prolong pregnancy and thereby increase birth weight. Objective We aimed to examine the relations of n–3 LCPUFA supplementation in pregnancy with duration of pregnancy, birth weight, and size for gestational age (GA). Methods This was a double-blind randomized controlled trial conducted in 736 pregnant women and their offspring, from the Copenhagen Prospective Studies on Asthma in Childhood2010cohort. They were recruited between weeks 22 and 26 in pregnancy and randomly assigned to either of 2.4 g n–3 LCPUFA or control (olive oil) daily until 1 wk after birth. Exclusion criteria were endocrine, cardiovascular, or nephrologic disorders and vitamin D supplementation intake >600 IU/d. In this study we analyzed secondary outcomes, and further excluded twin pregnancies and extrauterine death. The primary outcome for the trial was persistent wheeze or asthma. Results The random assignment ran between 2008 and 2010. Six hundred and ninety-nine mother-infant pairs were included in the analysis. n–3 LCPUFA compared with control was associated with a 2-d prolongation of pregnancy [median (IQR): 282 (275–288) d compared with 280 (273–286) d, P = 0.02], a 97-g higher birth weight (mean ± SD: 3601 ± 534 g compared with 3504 ± 528 g, P = 0.02), and an increased size for GA according to the Norwegian population-based growth curves-Skjærven (mean ± SD: 49.9 ± 28.3 percentiles compared with 44.5 ± 27.6 percentiles, P = 0.01). Conclusion Supplementing pregnant women with n–3 LCPUFAs during the third trimester is associated with prolonged gestation and increased size for GA, leading to a higher birth weight in this randomized controlled trial. This trial was registered at clinicaltrials.gov as NCT00798226.

Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis

2018 ◽  
Vol 36 (04) ◽  
pp. 366-376 ◽  
Author(s):  
Richard Burwick ◽  
Shravya Govindappagari
Keyword(s):  
Systematic Review ◽  
Iron Deficiency ◽  
Iron Deficiency Anemia ◽  
Meta Analysis ◽  
Oral Iron ◽  
Sensitivity Analyses ◽  
Deficiency Anemia ◽  
Iv Iron ◽  
Anemia In Pregnancy ◽  
In Pregnancy

Objective To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the benefits of intravenous (IV) iron in pregnancy. Study Design Systematic review was registered with PROSPERO and performed using PRISMA guidelines. PubMed, MEDLINE, Web of Science, ClinicalTrials.gov, Cochrane Library, and Google Scholar were searched. Eleven RCTs, comparing IV to oral iron for treatment of iron-deficiency anemia in pregnancy, were included. Meta-analyses were performed with Stata software (College Station, TX), utilizing random effects model and method of DerSimonian and Laird. Outcomes were assessed by pooled odds ratios (OR) or pooled weighted mean difference (WMD). Sensitivity analyses were performed for heterogeneity. Results We found that pregnant women receiving IV iron, compared with oral iron, had the following benefits: (1) Achieved target hemoglobin more often, pooled OR 2.66 (95% confidence interval [CI]: 1.71–4.15), p < 0.001; (2) Increased hemoglobin level after 4 weeks, pooled WMD 0.84 g/dL (95% CI: 0.59–1.09), p < 0.001; (3) Decreased adverse reactions, pooled OR 0.35 (95% CI: 0.18–0.67), p = 0.001. Results were unchanged following sensitivity analyses. Conclusion In this meta-analysis, IV iron is superior to oral iron for treatment of iron-deficiency anemia in pregnancy. Women receiving IV iron more often achieve desired hemoglobin targets, faster and with fewer side effects.

A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia

2013 ◽  
Vol 121 (2) ◽  
pp. 103-109 ◽  
Author(s):  
Elizabeth M. McClure ◽  
Robert L. Goldenberg ◽  
Arlene E. Dent ◽  
Steven R. Meshnick
Keyword(s):  
Systematic Review ◽  
Birth Weight ◽  
Low Birth Weight ◽  
Malaria Prevention ◽  
Maternal Anemia ◽  
The Impact ◽  
In Pregnancy

scholarly journals Association of Timing of Weight Gain in Pregnancy With Infant Birth Weight

2018 ◽  
Vol 172 (2) ◽  
pp. 136 ◽  
Author(s):  
Ravi Retnakaran ◽  
Shi Wu Wen ◽  
Hongzhuan Tan ◽  
Shujin Zhou ◽  
Chang Ye ◽  
...  
Keyword(s):  
Weight Gain ◽  
Birth Weight ◽  
Infant Birth ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document